| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ... Hepatology 65 (5), 1557-1565, 2017 | 2148 | 2017 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1384 | 2019 |
| Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr, JM Schattenberg, ... Gastroenterology 158 (6), 1611-1625. e12, 2020 | 1088 | 2020 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 493 | 2020 |
| Oxidative stress in liver pathophysiology and disease A Allameh, R Niayesh-Mehr, A Aliarab, G Sebastiani, K Pantopoulos Antioxidants 12 (9), 1653, 2023 | 411 | 2023 |
| Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy G Sebastiani, A Alberti World journal of gastroenterology: WJG 12 (23), 3682, 2006 | 375 | 2006 |
| Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C G Sebastiani, A Vario, M Guido, F Noventa, M Plebani, R Pistis, A Ferrari, ... Journal of hepatology 44 (4), 686-693, 2006 | 358 | 2006 |
| Limitations of non-invasive tests for assessment of liver fibrosis K Patel, G Sebastiani JHEP reports 2 (2), 100067, 2020 | 356 | 2020 |
| Chronic hepatitis C and liver fibrosis G Sebastiani, K Gkouvatsos, K Pantopoulos World journal of gastroenterology: WJG 20 (32), 11033, 2014 | 352 | 2014 |
| Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C L Castéra, G Sebastiani, B Le Bail, V de Lédinghen, P Couzigou, A Alberti Journal of hepatology 52 (2), 191-198, 2010 | 304 | 2010 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 260 | 2022 |
| Liver fibrosis: Review of current imaging and MRI quantification techniques L Petitclerc, G Sebastiani, G Gilbert, G Cloutier, A Tang Journal of Magnetic Resonance Imaging 45 (5), 1276-1295, 2017 | 251 | 2017 |
| SAFE biopsy: a validated method for large‐scale staging of liver fibrosis in chronic hepatitis C G Sebastiani, P Halfon, L Castera, S Pol, DL Thomas, A Mangia, ... Hepatology 49 (6), 1821-1827, 2009 | 248 | 2009 |
| Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study G Sebastiani, D Tempesta, G Fattovich, L Castera, P Halfon, M Bourliere, ... Journal of hepatology 53 (4), 630-638, 2010 | 213 | 2010 |
| Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B G Sebastiani, A Vario, M Guido, A Alberti World journal of gastroenterology: WJG 13 (4), 525, 2007 | 195 | 2007 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The lancet Gastroenterology & hepatology 8 (8), 704-713, 2023 | 192 | 2023 |
| 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 L Ryom, A Cotter, R De Miguel, C Béguelin, D Podlekareva, JR Arribas, ... HIV medicine 21 (10), 617-624, 2020 | 190 | 2020 |
| Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver … S Petta, G Sebastiani, M Viganò, J Ampuero, VWS Wong, J Boursier, ... Clinical gastroenterology and hepatology 19 (4), 806-815. e5, 2021 | 184 | 2021 |
| Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease G Feng, L Valenti, VWS Wong, YM Fouad, Y Yilmaz, W Kim, G Sebastiani, ... Nature Reviews Gastroenterology & Hepatology 21 (1), 46-56, 2024 | 179 | 2024 |
| An international multidisciplinary consensus statement on MAFLD and the risk of CVD XD Zhou, G Targher, CD Byrne, V Somers, SU Kim, CAA Chahal, ... Hepatology international 17 (4), 773-791, 2023 | 169 | 2023 |
ALFREDO ALBERTIUniversity of PadovaVerified email at unipd.it
